
The periorbital zone — the skin immediately surrounding the eyes, from the upper lid skin to the lower lid and extending to the outer corners — is one of the most technically challenging areas to treat in aesthetic medicine, precisely because its thinness and proximity to the eye demand a level of precision and safety that many resurfacing technologies cannot reliably provide. Ablative laser resurfacing, for example, while highly effective for skin resurfacing elsewhere on the face, carries elevated risks around the eye area that limit its suitability in this delicate zone for many patients.
LaseMD’s non-ablative thulium fractional laser is particularly well suited to the periorbital area. Its non-ablative mechanism — which stimulates collagen remodelling without destroying the skin surface — means it produces a meaningful resurfacing and skin quality improvement with a downtime of only one to three days of mild redness and dryness, rather than the week or more of healing associated with ablative resurfacing. Furthermore, it is safe across all skin types, removing the restriction that makes some other laser options less appropriate for patients with darker Fitzpatrick skin tones.
The result of a course of LaseMD eye treatments is a progressive improvement in the quality, texture and firmness of the periorbital skin — crepey texture is smoothed, fine lines become less prominent, the skin around the eyes appears healthier and more supported, and the overall quality and radiance of the eye area improves as collagen remodelling matures over the weeks following each session.
Our Doncaster clinic is on Thorne Road with on-site parking, and we welcome patients from across South Yorkshire including Rotherham, Wakefield, Sheffield, Leeds and Barnsley.
LaseMD uses a non-ablative thulium fractional laser to deliver its resurfacing effect. The thulium wavelength (1927nm) is highly absorbed by water in the skin tissue, creating precise micro-treatment zones in the dermis and superficial dermis without fully ablating the skin surface. This fractional delivery — treating columns of tissue with intervening untreated skin left intact — allows effective collagen stimulation with faster healing and less downtime than full-surface ablative treatments.
Why it is specifically suited to the eye area: The non-ablative mechanism means the skin surface remains intact, acting as its own biological dressing during the healing process. This reduces the risk profile for the delicate periorbital skin relative to ablative approaches. Additionally, LaseMD’s fractional delivery allows the energy parameters to be calibrated precisely for the thinner, more sensitive periorbital skin — a different set of parameters from those used for the full face.
The CDS ampoule system: LaseMD’s cosmeceutical delivery system (CDS) uses the fractional micro-channels created by the laser to deliver prescription-grade active ingredients — Vitamin A (retinol) or Vitamin C — directly into the skin at a depth and concentration that topical application cannot achieve. For the periorbital area, the CDS ampoule step enhances the collagen-stimulating and brightening benefits of the laser treatment, providing a targeted active ingredient delivery into the treated eye area skin immediately after laser energy is applied. The ampoule add-on is £30 per session.
What the biological response looks like: The thermal micro-zones created by LaseMD activate fibroblasts in the dermis, stimulating new collagen and elastin synthesis. The skin surface renews as the micro-treatment zones heal, improving surface texture. Collagen remodelling continues for four to six weeks after each session, with the full result of each treatment developing progressively over this period.
The clinical evidence for non-ablative fractional laser resurfacing in periorbital skin quality improvement is supported by peer-reviewed research. British Journal of Dermatology — non-ablative laser and periorbital skin
Before treatment:
During treatment:
After treatment:
The primary purpose of LaseMD eye treatment is to address the specific skin quality concerns of the periorbital zone — the crepey texture, fine lines and loss of smooth, plump skin quality that develop around the eyes — through a laser resurfacing mechanism that is calibrated for this delicate area. By stimulating new collagen and elastin formation in the periorbital dermis and triggering surface renewal, LaseMD produces a genuine structural improvement in the skin quality around the eyes that topical eye creams and non-energy treatments cannot match, because it works at the dermal level where the structural changes are actually occurring.
The collagen remodelling response triggered by each LaseMD eye treatment session develops and matures for four to six weeks post-treatment, and the results of a four-session course accumulate progressively — each session deepening and extending the remodelling response established by the previous one. Maintaining the improved periorbital skin quality achieved through a course requires ongoing attention — whether through annual or biannual LaseMD maintenance sessions or complementary eye area treatments. Your practitioner will discuss the most appropriate maintenance approach at your final treatment review.
For many people, the changes in the eye area — the crepey skin, the fine lines, the sense that the eyes look tired or older than the rest of the face — are among the most self-consciousness-inducing signs of ageing. The eye area is the first thing people look at in a face, and changes here are noticed earlier and more consistently than changes elsewhere. LaseMD eye treatment provides a non-surgical route to a genuine and meaningful improvement in periorbital skin quality — producing results that reflect a real structural change in the skin rather than a temporary surface effect, and restoring a rested, brighter and more youthful quality to the eye area that has a direct positive impact on confidence.
1. Safe and effective specifically in the periorbital zone LaseMD’s non-ablative mechanism and precise fractional delivery make it one of the most appropriate laser resurfacing options available for the thin, delicate skin around the eyes — an area where many more aggressive laser treatments carry elevated risk.
2. Improves crepey periorbital skin texture The collagen remodelling triggered by LaseMD progressively improves the crepey, thin texture of periorbital skin — restoring a smoother, more supported and plumper quality to the skin surface around the eyes over a course of sessions.
3. Reduces the appearance of periorbital fine lines New collagen formation in the dermis progressively fills and smooths the structural basis of fine periorbital lines — including the crow’s feet at the outer corners, the fine under-eye lines and the upper lid skin quality.
4. Minimal downtime of 1–3 days LaseMD’s non-ablative approach means the skin surface remains intact, allowing healing to complete quickly. One to three days of mild redness, dryness and possible light flaking is the typical experience — substantially less than the recovery associated with ablative eye area resurfacing.
5. Safe across all Fitzpatrick skin types Because LaseMD’s mechanism does not rely on melanin absorption, it is safe and effective across all skin types — including darker Fitzpatrick tones where some laser treatments carry elevated risk of post-inflammatory hyperpigmentation.
6. CDS ampoule delivers active ingredients directly into treated skin The optional CDS ampoule step uses the micro-channels created by the laser to deliver Vitamin A or Vitamin C into the periorbital skin at a depth and concentration that topical application cannot achieve, enhancing the collagen-stimulating and brightening benefits of the laser treatment.
7. Combines with full face LaseMD for comprehensive resurfacing LaseMD eye treatment is available as a standalone eye area session or combined with full face LaseMD treatment for patients who want comprehensive periorbital and facial resurfacing in a single appointment. Combination pricing is shown on the main LaseMD face treatment page.
Crepey Periorbital Skin
Crepey texture around the eyes — the fine, tissue-paper-like quality that develops as the periorbital skin loses collagen density and structural support — is one of the most common and most difficult periorbital concerns to address through non-laser approaches. LaseMD’s collagen stimulation progressively restores density to the periorbital dermis, improving the crepey quality and restoring a smoother, more plump skin appearance over a course of sessions.
Fine Periorbital Lines and Crow’s Feet
The lateral canthal lines (crow’s feet) that radiate from the outer corners of the eyes, the fine lines of the lower lid skin and the texture of the upper lid skin all respond to LaseMD’s collagen remodelling. The fractional laser creates the thermal stimulus required for new collagen synthesis in these areas, progressively improving the appearance of fine lines over the course.
Thinning and Fragile Upper and Lower Lid Skin
The upper and lower eyelid skin is among the thinnest on the body and is often among the first areas to develop a translucent, fragile quality as ageing progresses. LaseMD’s collagen stimulation improves the structural quality of this skin, restoring some of the density and resilience that ageing has diminished.
Dull or Uneven Periorbital Skin Tone
The surface renewal triggered by LaseMD’s fractional laser improves the overall clarity, evenness and radiance of the periorbital skin tone, addressing the dullness and uneven quality that can make the eye area look tired or aged.
Both CO2 eye treatment and LaseMD eye treatment use laser resurfacing to improve periorbital skin quality, but they sit at different levels of treatment intensity and are appropriate for different patients and concerns.
LaseMD eye treatment is non-ablative — the skin surface remains intact throughout the healing process, producing one to three days of mild redness and dryness. It is the appropriate choice for patients who want a meaningful improvement in periorbital skin quality with minimal downtime, or for patients who are earlier in their ageing journey and want a progressive maintenance approach.
CO2 eye treatment is ablative at its standard settings — the laser fully resurfaces the periorbital skin, producing more significant downtime of seven to ten days but a more dramatic collagen remodelling and resurfacing response. It is the appropriate choice for patients with more significant periorbital skin concerns — deeper lines, more pronounced laxity — who can accommodate the recovery period and want the most impactful non-surgical result available.
For patients who are unsure which is appropriate, the general principle is: LaseMD for progressive improvement with minimal recovery; CO2 for maximum impact with meaningful recovery. Your practitioner will discuss the most appropriate option for your periorbital concerns and downtime tolerance at consultation.
Polynucleotide eye treatment uses injectable polynucleotides placed around the periorbital area to stimulate deep tissue regeneration, improve skin quality and hydration, and address the structural changes around the eyes from below the skin surface.
LaseMD eye treatment uses laser energy to stimulate collagen remodelling at the surface and superficial dermis — improving skin texture, fine lines and overall quality from the skin surface inward.
The two treatments address the periorbital area through complementary mechanisms and can be used in sequence or as part of a comprehensive eye area programme. Polynucleotides provide deep tissue and hydration support; LaseMD provides surface resurfacing and collagen stimulation. Your practitioner will advise on the most appropriate single or combined approach for your specific eye area concerns at consultation.
The periorbital area requires a higher level of treatment precision and care than most other facial zones — thinner skin, proximity to the eye and the greater sensitivity of the area all demand careful parameter calibration and experienced technique. At Elements Medical, LaseMD eye treatment is performed by practitioners experienced in periorbital laser treatment, and every treatment begins with a thorough consultation and skin assessment before any laser energy is applied.
LaseMD eye treatment is part of our comprehensive eye treatment range, which also includes CO2 eye treatment, polynucleotide eye treatment and SuneKOS eye treatment. We will always recommend the treatment that is genuinely the best match for your periorbital concerns, skin type and downtime tolerance at consultation.
Read what our patients say on our Google Reviews page.
30 – 60 minutes
Depending on the idividual, results can be seen after 14 days
Depending on which treatment you have, potential side effects include, swelling, redness resembling sunburn and a tingling sensation
Downtime can vary from patient to patient, typically, you should expect to be a little pink when leaving after treatment, and peeling can occur post treatment.
LaseMD eye treatment uses a non-ablative thulium fractional laser to resurface and remodel the periorbital skin around the eyes — the upper and lower lid skin, under-eye area and outer corners. It improves crepey periorbital texture, fine periorbital lines including crow’s feet, overall skin quality and radiance in the eye area. It is non-ablative, meaning the skin surface remains intact, and produces one to three days of mild redness and dryness.
Yes. LaseMD’s non-ablative mechanism and fractional delivery make it particularly well suited to the thin, delicate periorbital skin. Protective eyewear is placed over the eyes throughout treatment to shield them from any light exposure. Treatment parameters are specifically calibrated for the periorbital zone — different from and gentler than the settings used for the full face.
A course of four sessions at four-week intervals is recommended for optimal results. Each session builds on the collagen remodelling response of the previous one, producing progressively greater improvement across the full course. Results from a single session are noticeable from seven to fourteen days post-treatment.
One to three days of mild redness, warmth and dryness in the periorbital area are typical, with possible mild swelling on the day of treatment and the morning after. Some patients experience light flaking or sloughing as the micro-treatment zones heal — this is normal and expected. Eye makeup should be avoided for 48 to 72 hours post-treatment. Most patients return to normal activities within one to three days.
The CDS (cosmeceutical delivery system) ampoule step uses the micro-channels created by the laser to deliver a prescription-grade active ingredient — Vitamin A (retinol) or Vitamin C — into the periorbital skin immediately after the laser treatment. The micro-channels allow significantly deeper and more concentrated delivery than topical application can achieve, enhancing the collagen-stimulating and brightening effects of the laser session. The ampoule add-on is £30 per session.
Initial improvement in periorbital skin quality becomes visible from seven to fourteen days post-treatment as the acute healing phase completes. Deeper collagen remodelling continues to develop for four to six weeks following each session. The full result of a four-session course is therefore seen at approximately four to six weeks after the final session — with progressive improvement throughout the post-course period.
LaseMD is non-ablative — the skin surface remains intact throughout, producing one to three days of mild recovery. CO2 is ablative, producing a more significant resurfacing response with seven to ten days of recovery but a more dramatic collagen remodelling outcome. LaseMD is the appropriate choice for patients who want meaningful improvement with minimal downtime; CO2 is the appropriate choice for more significant concerns with a recovery window. See our CO2 eye treatment page for more detail.
Yes — and this is the most popular approach for patients who want comprehensive periorbital and facial resurfacing together. The eye area is treated using parameters calibrated for the periorbital zone, and the full face is treated with the full face parameters in the same appointment. Combined pricing is shown on the LaseMD face treatment page.
LaseMD eye treatment is not recommended during pregnancy or breastfeeding.
Please read our disclaimer for more information
Select Your Treatment
Browse through our website and choose the treatment that’s right for you.
Book Online or Call Us
Follow the link below to book your treatment online. Or call us on 01302 34 34 32
Complete Your Forms
Your medical history form will be emailed for you to complete before you attend.
Select Your Treatment
Browse through our website and choose the treatment that’s right for you.
Book Online or Call Us
Follow the link below to book your treatment online. Or call us on 01302 34 34 32
Complete Your Forms
Your medical history form will be emailed for you to complete before you attend.
Call us: 01302 34 34 32
Email us: reception@elements.org.uk
Visit our Instagram
Visit our Facebook
Visit our TikTok
Contact us on WhatsApp